Recently, sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as a new class of drugs designed to treat patients with type 2 diabetes (T2D), but have also been shown to be protective against HF-related events and CV mortality
Studies show that adequate magnesium status is linked to better metabolic health and reduced inflammation, both of which support the long-term benefits of GLP-1 therapy beyond appetite suppression
In March, Roche and Zealand released Phase 2 clinical trial data for a once-weekly injection of petrelintide showing nearly 10% weight reduction among participants with minimal side effects
Azouz While research into GLP-1 drugs for lipedema continues, their demonstrated advantages for weight loss and inflammation make them an intriguing complement to lipedema treatment
Our Vitamin B12 boosters provide a quick and efficient way to replenish your body's stores of this vital nutrient, helping you feel more energised and revitalised
GHK is intended strictly for in vitro research applications
